OrthoPediatrics Executive and Leadership Team

Mark Throdahl, the President & Chief Executive Officer at OrthoPediatrics, directs the overarching corporate strategy and operational execution for the medical device company. Throdahl guides the design, development, and marketing of specialized orthopedic implants and instruments tailored for pediatric patients. This leadership role involves ensuring the company's product portfolio effectively addresses conditions such as pediatric trauma, deformity correction, and spinal deformities. Overseeing global market penetration, Throdahl drives initiatives to expand the company's reach in the United States and internationally. The Chief Executive Officer's focus remains on fostering innovation and maintaining the company's commitment to providing anatomically appropriate solutions for children's orthopedic needs. Mark Throdahl's strategic vision ensures OrthoPediatrics remains at the forefront of pediatric orthopedic care, impacting patient outcomes through advanced medical technology.

David Bailey, the President & Chief Executive Officer at OrthoPediatrics, spearheads the company's strategic direction and overall business performance. Bailey's leadership encompasses the critical functions of designing, developing, and marketing anatomically appropriate orthopedic solutions for children. This executive oversees the expansion of product lines, including pediatric trauma and deformity correction, scoliosis procedures, and sports medicine offerings. The Chief Executive Officer's responsibilities extend to driving international growth and solidifying the company's presence in key global markets. David Bailey ensures that OrthoPediatrics consistently delivers innovative medical devices that meet the unique orthopedic needs of pediatric patients. Through strategic oversight, Bailey champions the company's mission to improve the lives of children facing orthopedic challenges, maintaining a strong focus on market leadership and product excellence.

Timothy Hinspeter, the President, Trauma Recon Corporate (An Orthopediatrics Distributor) at OrthoPediatrics, manages the distribution and market presence of trauma and reconstruction products. Hinspeter directs sales and operational strategies for a key segment of OrthoPediatrics' offerings, ensuring efficient delivery of specialized orthopedic devices to healthcare providers. This role involves cultivating strong relationships with healthcare professionals and managing the supply chain for trauma and deformity correction solutions. The President's focus is on expanding market access and driving adoption of these critical pediatric orthopedic technologies. Timothy Hinspeter's leadership ensures that the trauma and reconstruction product lines reach the intended patient populations effectively, supporting the company's mission to provide anatomically appropriate care for children. Hinspeter's operational expertise is vital for the successful deployment of these specialized medical devices.

Joseph Hauser, the President, Trauma & Deformity Business at OrthoPediatrics, leads the strategic development and commercialization of products addressing pediatric trauma and skeletal deformities. Hauser directs the innovation pipeline for this critical business segment, ensuring the design and delivery of anatomically appropriate implants and instruments. This executive oversees market strategies aimed at increasing the adoption of trauma and deformity correction solutions across the United States and international markets. Joseph Hauser's responsibilities include fostering collaborations with orthopedic surgeons and driving the growth of this specialized product category. The President's leadership ensures that OrthoPediatrics continues to provide cutting-edge solutions for complex pediatric orthopedic conditions, directly impacting patient care and recovery. Hauser's focus on this specific business area is crucial for advancing the company's specialized offerings.

Gregory Odle, the President - Scoliosis at OrthoPediatrics, spearheads the strategic initiatives and market development for the company's scoliosis treatment solutions. Odle directs the advancement and commercialization of specialized implants and instruments designed for pediatric spinal deformity correction. This leadership role involves driving innovation in scoliosis procedures and ensuring the effective delivery of these treatments to young patients. Gregory Odle oversees market penetration strategies, aiming to expand the reach of OrthoPediatrics' scoliosis product portfolio both domestically and internationally. The President's focus is on enhancing patient outcomes through advanced, anatomically appropriate orthopedic devices. Odle's dedicated leadership in the scoliosis segment is essential for addressing the unique challenges of spinal deformities in children and reinforcing OrthoPediatrics' position as a leader in pediatric orthopedics.